Accepted Papers and Posters

*Denotes selected as a platform session.

PDF of accepted abstracts | Poster Guidelines | Searchable Abstract Database | Pediatric Blood & Cancer Online Abstracts

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z

Joseph Abdul-Malak	316
EFFECTS OF HYDROXYUREA ON PULMONARY HYPERTENSION IN SPLENECTOMIZED CHILDREN WITH SCD
Shirley Abraham	511
COMPARING GFR ESTIMATING EQUATIONS, 24-HOUR URINE AND MEASURED IOHEXOL GFR IN PEDIATRIC PATIENTS WITH CANCER
Denise Adams	414
PHASE II STUDY OF SIROLIMUS AND COMPLICATED VASCULAR ANOMALIES: LONG TERM OUTCOMES IN KAPOSIFORM HEMANGIOENDOTHELIOMA
Denise Adams	416
A MULTI-INSTITUTIONAL RETROSPECTIVE ANALYSIS OF SIROLIMUS AND BISPHOSPHONATES FOR THE TREATMENT OF GENERALIZED LYMPHATIC ANOMALY (GLA) AND GORHAM-STOUT DISEASE (GSD)
Denise Adams	424
CHARACTERIZATION OF LONG-TERM OUTCOMES FOR PEDIATRIC PATIENTS WITH EXTRAHEPATIC EPITHELIOID HEMANGIOMA
Olubunmi Afonja	429
BAY 81-8973 PROPHYLAXIS FREQUENCY AND PHARMACOKINETICS IN RELATION TO BLEEDING RATES IN PEDIATRIC PATIENTS: SUBANALYSIS OF LEOPOLD KIDS DATA
Shreya Agarwal	051
RELAPSE OF T CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER MORE THAN TEN YEARS: TRUE RELAPSE OR SECOND MALIGNANCY?
Shreya Agarwal	082
TEENAGER WITH ATRAUMATIC COMPARTMENT SYNDROME: A RARE CASE OF ACQUIRED HEMOPHILIA A
Jennifer Agrusa	659
CHARACTERIZING PULMONARY DYSFUNCTION IN SURVIVORS OF CHILDHOOD HODGKIN LYMPHOMA
Maria Ahmad-Nabi	086
SUCCESSFUL IMMUNE TOLERANCE IN FACTOR IX DEFICIENCY PATIENTS WITH CYCLOPHOSPHAMIDE AND RITUXIMAB
Maria Ahmad-Nabi	431
RISK FACTORS AND OUTCOMES OF DEEP VEIN THROMBOSIS IN PEDIATRIC OSTEOMYELITIS
Rafat Ahmed	358
FAT EMBOLISM SYNDROME IN SICKLE CELL SC DISEASE: A CASE PRESENTATION AND REVIEW
Sanjay Ahuja	419
EFFECTIVE PROPHYLAXIS WITH BAY 94-9027 IN ADOLESCENTS WITH HEMOPHILIA A: RESULTS FROM THE PROTECT VIII MAIN STUDY AND ONGOING EXTENSION
Hebah Al Absi	070
CONGENITALCOMBINED DEFICIENCY OF THE VITAMIN K-DEPENDENT CLOTTING FACTORS (VKCFD): A NOVEL HOMOZYGOUS MISSENSE GAMMA-GLUTAMYL CARBOXYLASE (GGCX) MUTATION
Khalfan Al Senaidi	202
DIASTOLIC DYSFUNCTION IN NON TRASNFUSED β THALASSAEMIA INTERMEDIA: CASE CONTROL STUDY
Neena Alex	334
THE ROLE OF FOLATE SUPPLEMENTATION IN IMPROVING CLINICAL OUTCOMES IN CHILDREN WITH SICKLE CELL DISEASE
Nesreen Ali	029
HEMOPHILIA AND CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Jenna Allison	038
A CASE SERIES OF TWO UNIQUE CNS TUMOR DIAGNOSES PRESENTING AS LEPTOMENINGEAL DISEASE
Warren Alperstein	099
A UNIQUE CASE OF BCOR+ UNDIFFERENTIATED SARCOMA- A NEW SUBTYPE OF SARCOMA
Warren Alperstein	006
AN EXTRA-RENAL WILMS' TUMOR PRESENTING AS A UTERINE MASS
Warren Alperstein	920
STEROID DEPENDENT GRAFT-VERSUS-HOST-DISEASE MANAGED WITH WEEKLY BORTEZOMIB
Ali Amid	313
OPTIMIZING TRANSFUSION THERAPY FOR SURVIVORS OF HEMOGLOBIN BARTS HYDROPS FETALIS: DEFINING THE OPTIMAL TARGETS FOR HEMOGLOBIN H AND “FUNCTIONAL” EMOGLOBIN LEVELS.
Reuben Antony	654
PREGNANCY IN A YOUNG ADULT TREATED FOR ANAPLASTIC ASTROCYTOMA WITH RADIATION THERAPY AND BEVACIZUMAB
Claire Arbitre	357
EVALUATION OF VASO-OCCLUSIVE CRISIS MANAGEMENT WITH PATIENT CONTROLLED ANALGESIA IN CHILDREN WITH SICKLE CELL DISEASE REQUIRING ADMISSION
Paula Aristizabal	623
EDUCATING THE NEXT GENERATION: DEVELOPMENT AND IMPLEMENTATION OF A DELIVERY OF INFORMED CONSENT CURRICULUM FOR PEDIATRIC HEMATOLOGY/ONCOLOGY ELLOWS TO ENHANCE COMMUNICATION SKILLS
Paula Artistizabal	661
FACTORS AFFECTING COMPREHENSION AND VOLUNTARINESS DURING INFORMED CONSENT IN PEDIATRIC ONCOLOGY
Amy Armstrong	504
NON-INVASIVE PATHOGEN DETECTION IN PEDIATRIC ONCOLOGY AND HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS AT RISK FOR DEEP FUNGAL INFECTIONS USING NEXT GENERATION SEQUENCING
Akua Asante	2028
PLATELET ONTOGENY: A CLOSER LOOK AT PLATELET IMMUNE FUNCTION*
Claire Atkinson	727
COMPLICATIONS ASSOCIATED WITH PLACING A PORT VERSUS AN EXTERNAL CATHETER DURING INDUCTION THERAPY IN CHILDREN DIAGNOSED WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Mark Atlas	639
GENETICS/GENOMICS CURRICULUM FOR PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWS
Marie Claire Milady Auguste	740
EPIDEMIOLOGICAL PROFILE OF LYMPHOMAS MANAGED AT A PEDIATRIC HOSPITAL IN PORT-AU-PRINCE, HAITI, FROM JANUARY 2006 TO DECEMBER 2016
Waitman Aumann	2021
THE SIX1 HOMEOBOX GENE IS A NOVEL CRM1-DEPENDENT TARGET IN CALM-AF10 LEUKEMIAS*
Rakesh Awasthi	709
PHARMACOKINETICS AND PHARMACODYNAMICS OF TOCILIZUMAB FOR THE MANAGEMENT OF CYTOKINE RELEASE SYNDROME (CRS) IN PEDIATRIC AND YOUNG-ADULT PATIENTS WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) TREATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY TISAGENLECLEUCEL (CTL019)
Arahana Awasthi	750
POLATUZUMAB VEDOTIN (PV) ALONE OR IN-COMBINATION WITH OBINUTUZUMAB SIGNIFICANTLY ENHANCES IN-VITRO/IN-VIVO CYTOTOXICITY AGAINST BURKITT LYMPHOMA (BL) /PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA (PMBL)
Jamie Aye	825
KINOMIC ALTERATIONS OF PRIMARY AND METASTATIC WILMS TUMOR BY FOCAL ADHESION KINASE INHIBITION
Asmaa Azab	346
A COMPARISON STUDY OF PULMONARY FUNCTION IN AMERICAN AND KUWITI CHILDREN WITH SICKLE CELL DISEASE
Priscila Badia	420
TOPICAL SIROLIMUS FOR CUTANEOUS MANIFESTATIONS OF VASCULAR MALFORMATIONS
Aditi Bagchi	2005
MUTATIONAL SIGNATURES AND IMMUNOPHENOTYPE IN RECURRENT MEDULLOBLASTOMA: AN INDICATION FOR NOVEL THERAPEUTIC APPROACH*
Kelly Bailey	842
THE EWS-FLI1 ONCOPROTEIN LEVEL MODULATES CXCR4/CXCR7-NF-KB SIGNALING IN EWING SARCOMA.
Nitya Bakshi	666
PATIENTS WITH SICKLE CELL DISEASE AND THEIR CAREGIVERS WANT TO LEARN ABOUT BONE MARROW TRANSPLANT AS A TREATMENT OPTION
Michael Barbato	608
CNS TUMORS AND NEURODEVELOPMENTAL DISORDERS: A BRIEF SURVEY OF IN COMMON GENE ALTERATIONS
Gino Jose Bardi Lola	014
OSTEOSARCOMA IN A CHILD WITH NEUROFIBROMATOSIS TYPE 1: A CASE REPORT AND REVIEW OF THE LITERATURE.
Erin Barr	829
THE EPIGENETIC MARKER 5-HYDROXYMETHYLCYTOSINE REVEALS DIFFERENTIAL PROFILES IN LOW-, INTERMEDIATE-, AND HIGH-RISK NEUROBLASTOMA AND IDENTIFIES COPY NUMBER VARIANTS
Joy Bartholomew	827
OUTPATIENT INTERLEUKIN 2 MAY BE A SAFE AND FEASIBLE OPTION IN CHILDREN WITH HIGH RISK NEUROBLASTOMA
Allison Bartlett	066
HEREDITARY XEROCYTOSIS MISDIAGNOSED AS HEREDITARY SPHEROCYTOSIS
Jacquelyn Baskin	339
AURA ASSOCIATED WITH SICKLE CELL PAIN: A MOBILE PHONE APPLICATION TO STUDY THE RELATION BETWEEN THE DYSAUTONOMIA OF SICKLE CELL DISEASE AND SUBSEQUENT PAIN
Allison Bechtel	516
A KNOWLEDGE SCREENING EDUCATION SYSTEM IN ADOLESCENTS WITH SICKLE CELL DISEASE
Allison Bechtel	822
ENTERAL TUBE NUTRITION NEEDS AND PERCEPTIONS IN HIGH-RISK HEAD AND NECK PEDIATRIC PATIENTS RECEIVING PROTON THERAPY
Kerri Becktell	046
RESOLUTION OF DIFFUSE LEPTOMENINGEAL ENHANCEMENT AFTER PRIMARY RESECTION OF ATYPICAL TERATOID/RHABDOID TUMOR
Tessa Bendyshe-Walton	649
DEVELOPMENT AND IMPLEMENTATION OF PHARMACOGENETIC RISK PREDICTION MODELS IN PEDIATRIC ONCOLOGY
Heather Bernard	096
THE NOVEL USE OF DEFEROXAMINE IN A NEONATE WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE II
Sucharita Bhaumik	047
PRIMARY EWINGS SARCOMA OF CERVICAL CORD MIMICKING CAUDA EQUINA SYNDROME
Sucharita Bhaumik	406
MEDICAL MANAGEMENT IN A CASE OF SPLENOSIS IN A RELAPSED IMMUNE THROMBOCYTOPENIC PURPURA PATIENT
Sucharita Bhaumik	512
MANAGEMENT OF EARLY SEPSIS IN NEUTROPENIC PEDIATRIC ONCOLOGY PATIENTS IN AN ARTICLE 28 INSTITUTION IN THE OUTPATIENT SETTING TO OPTIMIZE PATIENT OUTCOME.
Nabanita Bhunia	818
TARGETING PHOSPHORYLATION OF EZRIN IN METASTATIC RHABDOMYOSARCOMA
Vandy Black	340
CLINICAL OUTCOMES OF CHILDREN WITH SICKLE CELL DISEASE HOSPITALIZED FOR FEVER
Vandy Black	611
EVALUATING THE PROFESSIONAL DEVELOPMENT NEEDS OF PEDIATRIC HEMATOLOGISTS-ONCOLOGISTS SERVING IN THE UNITED STATES MILITARY
Lindsay Blazin	753
'I’M GOING TO CHURCH ANYWAY': THE IMPACT OF SPIRITUALITY ON GRIEVING FOR PARENTS WHO HAVE LOST CHILDREN TO CANCER
Ellen Bloom	329
PSYCHOSOCIAL RISK FACTORS OF SEVERITY OF SICKLE CELL DISEASE IN YOUNG CHILDREN
Julie Boiko	764
FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN AN ADOLESCENT PRESENTING WITH NEUROPSYCHIATRIC CHANGES IN THE ABSENCE OF CLASSIC SYSTEMIC SIGNS
Ashley Bonheur	053
A COMPLEX TRANSLOCATION INVOLVING CHROMOSOMES 2, 7, AND 12 IN A CASE OF PEDIATRIC WILMS TUMOR
Geetanjali Bora	217
FACTORS AFFECTING BONE MINERAL DENSITY IN YOUNG CHILDREN AND ADOLESCENTS WITH TRANSFUSION DEPENDENT THALASSEMIA
Bruce Bostrom	749
CAN PROPHYLACTIC PAMIDRONATE INFUSIONS REDUCE THE INCIDENCE OF SYMPTOMATIC OSTEONECROSIS IN PATIENTS AT HIGH RISK?
Alexander Boucher	105
DOSE MODIFICATIONS AND PHARMACOKINETICS OF CISPLATIN MONOTHERAPY FOR THREE PATIENTS WITH LOW-RISK HEPATOBLASTOMA AND DIALYSIS-DEPENDENT END-STAGE RENAL DISEASE
Alisha Bouzaher	528
A PATIENT-CENTERED INTERVENTION TO IMPROVE THE TIME-TO-ANTIBIOTICS FOR PEDIATRIC FEBRILE NEUTROPENIA PATIENTS AT A LARGE ACADEMIC MEDICAL CENTER
Leah Bruno	102
A CASE OF ATYPICAL HUS IN THE ABSENCE OF SCHISTOCYTES
Jochen Buechner	751
MANAGEMENT OF COAGULOPATHY ASSOCIATED WITH TISAGENLECLEUCEL CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY
Kenneth Bujold
TREATMENT OF RELAPSED ACUTE MYELOID LEUKEMIA PRESENTING AS INTRACRANIAL MYELOID SARCOMA: A CASE SERIES
Kenneth Bujold	425
CONTINUOUS LOW-DOSE HEPARIN INFUSION FOR CATHETER RELATED THROMBOSIS PROPHYLAXIS IN CRITICALLY ILL CHILDREN
James Bussel	421
FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
James Bussel	427
A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Daniel Callaway	354
PHYSICAL THERAPY IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH SICKLE CELL DISEASE: ASSESSING POTENTIAL BENEFITS AND BARRIERS
Kevin Campbell	824
EWING SARCOMA VS. PNET: COMPARING EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOMES OVER 40 YEARS USING SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS DATA.
Daniel Cannone	635
INITIAL SUCCESS OF AN INTERDISCIPLINARY COMMUNICATION COURSE FOR FELLOWS
Ivana Capin	024
A NOVEL APC MUTATION IN A TEENAGE PATIENT WITH A LARGE INTRA-ABDOMINAL DESMOID TUMOR
Maria Carter Febres	804
TARGETING BRAIN TUMOR STEM-LIKE CELLS WITH ATYPICAL ANTIPSYCHOTIC DRUGS
Christina Caruso	324
THE SIGNIFICANCE OF EARLY TRANSFUSION IN THE MANAGEMENT OF ACUTE CHEST SYNDROME IN PATIENTS WITH SICKLE CELL DISEASE
Jamie Cashell	643
RETENTION OF VACCINE-MEDIATED HUMORAL IMMUNITY IN THE POST-THERAPY PEDIATRIC ONCOLOGY POPULATION
Angel Castro Dager	330
STANDARDIZATION OF A NEW PARTIAL EXCHANGE TRANSFUSION PROTOCOL IN A PEDIATRIC POPULATION WITH SICKLE CELL DISEASE IN CARTAGENA, COLOMBIA
Priya Chan	816
EXTRANEURAL METASTASES OF A WHO GRADE II EPENDYMOMA: A CASE REPORT AND REVIEW OF THE LITERATURE
Simone Chang	091
MULTIPLE SITES OF EXTRAMEDULLARY RELAPSE ON BLINATUMOMAB: A PEDIATRIC CASE REPORT
Karen Chao	770
MONOTHERAPY TREATMENT WITH CYTARABINE FOR ALK-POSITIVE HISTIOCYTOSIS IN AN INFANT
Chen-Chen Cheng	624
BRING THE CLASS TO THE HOSPITAL: SUCCESS STORIES OF CHILDHOOD CANCER SURVIVORS RETURNING TO MIDDLE SCHOOL IN TAIWAN AND WHAT WE CAN LEARN FROM THEM
May Chien	054
CLINICAL OUTCOME OF HB KHARTOUM/β THALASSEMIA COMPOUND HETEROZYGOSITY: A GLIMPSE INTO HOMOZYGOUS HB KHARTOUM
May Chien	430
ANTICOAGULATION FOR TREATMENT OF PAIN IN VENOUS MALFORMATIONS
Soohee Cho	061
CHOLELITHIASIS IN PATIENTS WITH CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
Florence Choo	523
ADHERENCE TO ANTIEMETIC GUIDELINES IN PEDIATRIC PATIENTS WITH CANCER: HOW DO WE TRANSLATE EVIDENCE INTO PRACTICE?
Trixy Chu	737
SURVIVAL OF FILIPINO CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSED IN A TERTIARY REFERRAL CENTER FOR CHILDHOOD CANCER: A RETROSPECTIVE COHORT STUDY
David Claassen	311
CHARACTERIZATION, TREATMENT, AND TOXICITIES IN A PEDIATRIC DIAMOND BLACKFAN ANEMIA COHORT
Allison Close	110
THE PROOF IS IN THE PUDDING: A CASE OF COPPER DEFICIENCY CAUSING CYTOPENIAS IN A FOOD RESTRICTED CHILD
Allison Close	520
IMPROVING THE EVALUATION AND MANAGEMENT OF ABNORMAL UTERINE BLEEDING IN ADOLESCENT FEMALES PRESENTING TO EMERGENCY CARE
Clay Cohen	440
FIRST CASE OF CYTOPENIAS IN THE SETTING OF CEREBRAL CAVERNOUS MALFORMATION 3
Christina Coleman Abadi	020
PROLONGED SURVIVAL AND EVENTUAL DEATH BY DISSEMINATED PULMONARY METASTASIS IN A PEDIATRIC PATIENT WITH DIFFUSE PONTINE H3.1K27M GLIOMA: A CASE REPORT
James Cooper	437
VON WILLEBRAND DISEASE, DDAVP, AND FLUID MANAGEMENT IN PEDIATRIC SURGICAL PATIENTS
Stacy Cooper	506
COMMUNICATION OF PEDIATRIC CANCER DIAGNOSES: THE EXPERIENCES OF CAREGIVERS, PATIENTS AND GENERAL PEDIATRIC PROVIDERS
Elizabeth Cowell	826
DEFINITION OF RISK PROFILE AND TOXICITIES OF HIGH-DOSE METHOTREXATE USE IN PEDIATRIC OSTEOSARCOMA
Shelley Crary	418
EFFECT OF SIROLIMUS ON COAGULOPATHY OF SLOW-FLOW VASCULAR MALFORMATIONS
Ashley Cronkright	215
THE FAMILIES WITH ADOPTED CHILDREN WITH THALASSEMIA STUDY (FACT STUDY)
Courtney Culbertson	641
NUTRTIONAL STATUS AND NUTRIONAL SUPPORT THERAPY AFTER ONCOLOGIC DIAGNOSIS: A RETROSPECTIVE, DESCRIPTIVE STUDY
Ahmed Daak	2012
ClINICAL EFFECT OF SC411 (AlTEMIA TM) ON CHILDREN WITH SICKLE CELL DISEASE IN THE SCOT TRIAL: A PHASE 2 RANDOMIZED, DOUBL-BLIND, PLACEBO-CONTROLED, RALLEL-GROUP, DOSE-FINDING MULTI-CENTER STUDY*
Ahmed Daak	353
EFFECTS OF SC411 (ALTEMIATM) ON BLOOD CELL MEMBRANE OMEGA-3 INDEX AND SELECT SICKLE CELL DISEASE BIOMARKERS IN THE SCOT TRIAL: A Phase 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-COMTROLLED, PARALLEL-GROUP, MULTI-CENTER STUDY
Scott Daigle	2007
PHASE 1 STUDY OF THE EZH2 INHIBITOR, TAZEMETOSTAT, IN CHILDREN WITH RELAPSED OR REFRACTORY INI1-NEGATIVE TUMORS INCLUDING RHABDOID TUMORS, EPITHELIOID SARCOMA, CHORDOMA; AND SYNOVIAL SARCOMA*
Monica Davini	525
ROUTINE IMAGING FOR DETECTION OF RELAPSE AND ASSESSING TREATMENT RESPONSE IN ALPHA FETO PROTEIN (AFP) POSITIVE HEPATOBLASTOMA- IS IT REALLY NECESSARY?
Matthew Davis	2008
CHANGES IN ANTIEMETIC PRESCRIBING PRACTICES FOR CHILDREN RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY*
Kyle Davis	415
HEMATURIA PREVALENCE IN PEDIATRIC PATIENTS WITH HEMOPHILIA: A NATIONAL DATABASE REVIEW
Michelina de la Maza	208
ABATACEPT FOR MANAGEMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA
Jennifer Dean	636
PHYSICAL ACTIVITY INITIATIVE IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS: A PILOT STUDY
Christopher Denton	350
METHODOLOGICAL DIFFERENCES IN MEASUREMENT ALTERS AGGREGATION RESULTS IN PATIENTS WITH SICKLE CELL DISEASE VERSUS HEALTHY SUBJECTS
Brittany DePriest	914
ASSESSMENT OF IRON OVERLOAD IN THE PEDIATRIC ALLOGENEIC HSCT RECIPIENT
Yaser Diab	409
EXTREMITY DEEP VENOUS THROMBOSIS IN ASSOCIATION WITH VENOUS ANATOMIC ABNORMALITIES: INCIDENCE, CHARACTERISTICS AND OUTCOMES OF MULTIDISCIPLINARY CARE AT A SINGLE PEDIATRIC CENTER
Yaser Diab	423
ACUTE INFECTIONS AND VENOUS THROMBOEMBOLISM IN CHILDREN: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
Rosa Diaz	439
PREVALENCE AND BLEEDING PHENOTYPE OF COMBINED DEFICIENCIES IN FACTOR VIII AND VON WILLEBRAND FACTOR
Dragon Do	722
EFFECTS OF DISRUPTION OF PIRNA PATHWAY IN AML CELL LINES TREATED WITH DNA METHYLTRANSFERASE INHIBITORS
Erin Doherty	708
INDUCIBLE COSTIMULATION TO ENHANCE THE ANTI-AML ACTIVITY OF CD123-ENG T-CELLS
Elizabeth Donovan	626
A PATIENT-CENTERED APPROACH TO DEVELOPING A MOBILE-BASED PSYCHOSOCIAL INTERVENTION FOR ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA
Lauren Draper	519
CAREGIVER DECISION-MAKING REGARDING ENROLLMENT IN CHILDREN'S ONCOLOGY GROUP THERAPEUTIC TRIALS
Lucy Duan	438
LIFE-THREATENING EFFUSIONS IN KAPOSIFORM HEMANGIOENDOTHELIOMA RESPONDING TO ORAL RAPAMYCIN
Caitlyn Duffy	717
STEROID INDUCED BRADYCARDIA IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Olive Eckstein	754
CLINICAL OUTCOMES WITH MAPK INHIBITION IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS
Karen Effinger	604
OUTCOMES WITHIN FIVE YEARS FROM THERAPY COMPLETION IN PEDIATRIC HODGKIN LYMPHOMA PATIENTS FOLLOWING CONTEMPORARY THERAPY
Karen Effinger	614
WORKING TO STANDARDIZE CARDIOLOGY CARE IN SURVIVORS OF CHILDHOOD CANCER: A PEDIATRIC CARDIO-ONCOLOGY SCORE
Ahmed Elgammal	742
DOES CONSOLIDATION RADIOTHERAPY IMPROVES THE OUTCOME OF CHILDREN WITH STAGE IV HODGKIN LYMPHOMA IN COMBINATION TO CHEMOTHERAPY?
Ahmed Elhussein	744
ROLE OF FDG-PET/CT IN THE MANAGEMENT OF PEDIATRIC BURKITT LYMPHOMA
Hannah Elkus	814
IMPACT OF INFECTIONS ON SURVIVAL IN PEDIATRIC PATIENTS WITH BONE TUMORS
Amr Elnashar	761
PROTECTIVE EFFECT OF DICLOFENAC AND ENOXAPARIN IN L-ASPARAGINASE INDUCED ACUTE PANCREATITIS IN RATS
Elissa Engel	056
SUCCESSFUL USE OF ELTROMBOPAG IN A PEDIATRIC PATIENT WITH HIV-RELATED THROMBOCYTOPENIA
Huseyin Erdemir	748
INCREASED TUMOR GROWTH AND ANGIOGENESIS IN ABSENCE OF KININOGEN IN T-CELL LYMPHOMA MURINE MODEL
Adam Esbenshade	602
PREVALENCE OF INTERNALIZING PROBLEMS IN PEDIATRIC CANCER PATIENTS AT ENTRY INTO A SURVIVORSHIP CLINIC
Adam Esbenshade	664
INDICATIONS FOR EXPANSION OF EMPIRIC ANTIBIOTIC COVERAGE IN FEBRILE NEUTROPENIA IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS
Orlando Esparza	071
A UNIQUE PHENOTYPE OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A PATIENT WITH GATA2 DEFICIENCY
Justin Farge	735
GRANULOCYTIC SARCOMAS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
Sana Farooki	031
SAMD9 MUTATION ASSOCIATED BONE MARROW FAILURE TREATED WITH BONE MARROW TRANSPLANT: A UNIQUE TREATMENT APPROACH TO A RARE CASE
Sameer Farouk Sait	026
EXTRANEURAL METASTASES IN PEDIATRIC GLIOBLASTOMA MULTIFORME - A CASE REPORT AND LITERATURE REVIEW
Titilope Fasipe	310
IDENTIFICATION OF SICKLE CELL SUPER-UTILIZATION, A SINGLE INSTITUTION EXPERIENCE
Mohamed Fawzy	833
WATCH AND SEE STRATEGY IN SELECTED NEUROBLASTOMA CASE SCENARIOS; SUCCESS AND LIMITATIONS
Kathleen Felton	021
DIAGNOSIS AND MANAGEMENT OF VON WILLEBRAND DISEASE TYPE 2B IN A PATIENT WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Angela Feraco	651
THE DAY 100 TALK: FEASIBILITY AND ACCEPTABILITY OF A STRUCTURED INTERDISCIPLINARY COMMUNICATION INTERVENTION TARGETED TO THE EARLY TREATMENT PERIOD FOR CHILDHOOD CANCERS
Karen Fernandez	087
RITUXIMAB FOR ADVANCED BURKITT LYMPHOMA IN A PATIENT WITH DEFECTIVE CELL MEDIATED IMMUNITY DUE TO CARTILAGE-HAIR HYPOPLASIA (CHH)
Karen Fernandez	422
UNDERSTANDING THE IMMUNE STATUS OF PATIENTS WITH NON-COMPLICATED VASCULAR OR LYMPHATIC ANOMALIES TREATED WITH SIROLIMUS
Karen Fernandez	736
RARE PRESENTATIONS OF HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS: A MULTICENTER EXPERIENCE IN LATIN AMERICA AND THE UNITED STATES
Karen Fernandez	746
HODGKIN LYMPHOMA AND TUBERCULOSIS IN CHILDREN AND ADOLESCENTS IN GUATEMALA AND ARGENTINA
Patrick Fogarty	435
ANALYSIS OF REAL-WORLD CLAIMS DATA ASSOCIATED WITH A STANDARD AND AN EXTENDED HALF-LIFE RECOMBINANT FACTOR IX PRODUCT IN U.S. PEDIATRIC PATIENTS WITH HEMOPHILIA B
Kayla Foster	060
CONGENITAL SIDEROBLASTIC ANEMIA, IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY SYNDROME MASQUERADING AS ALPHA THALASSEMIA VARIANT
Ashley Foster Lanzel	412
ETHICAL DECISION MAKING FRAMEWORK IN PREVIOUSLY UNTREATED SEVERE HEMOPHILIA A PATIENTS
Ashley Foster Lanzel	665
DECISION-MAKING IN THE FACE OF INCURABLE HIGH GRADE GLIOMAS: A QUALITATIVE ETHICAL ANALYSIS
Ellen Fraint	916
UNUSUAL NEUROLOGIC SEQUELAE AFTER POST-TRANSPLANT ACUTE LIMBIC ENCEPHALITIS DUE TO HHV-6 INFECTION
Natasha Frederick	645
IDENTIFYING OPPORTUNITIES FOR IMPROVED COMMUNICATION BETWEEN ADOLESCENT AND YOUNG ADULT ONCOLOGY PATIENTS AND THEIR ONCOLOGY CLINICIANS
Natasha Frederick	667
LET'S TALK ABOUT SEX: ADOLESCENT AND YOUNG ADULT CANCER PATIENT SEXUAL AND REPRODUCTIVE HEALTH COMMUNICATION NEEDS
Carol Fries Simpson	074
WHEN THE HISTORY TELLS THE STORY: A CASE OF VITAMIN B12 DEFICIENCY DISCOVERED IN AN EXCLUSIVELY BREASTFED INFANT WITH PALLOR AND FAILURE TO THRIVE
Carol Fries Simpson	745
ULTRA-DEEP SEQUENCING DEMONSTRATES VARYING CLONAL COMPOSITION BETWEEN DISEASE SITES IN B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B ALL)
Carol Fries Simpson	918
HIGH DOSE CHEMOTHERAPY WITH CARBOPLATIN AND THIOTEPA WITH AUTOLOGOUS STEM CELL RESCUE IS A FEASIBLE AND WELL-TOLERATED THERAPY FOR MALIGNANT CNS TUMORS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE
Jordan Fritch	830
COMBINATION THERAPY OF POLYMERIC CHLOROQUINE AND DOXORUBICIN TO TREAT PULMONARY METASTATIC OSTEOSARCOMA
Stephanie Fritch Lilla	209
SHORT-TERM HIGH-DOSE INTRAVENOUS DEFEROXAMINE AS COMBINATION THERAPY FOR REDUCTION OF IRON IN PATIENTS WITH PERSISTENT IRON OVERLOAD
Kari Galipp	090
DIAGNOSING VITAMIN B12 DEFICIENCY ANEMIA IN A CHILD WITH A COMPLEX HEMATOLOGICAL PRESENTATION
Kari Galipp	092
CASE REPORT: CYCLIC NEUTROPENIA AND ASSOCIATED AMYLOIDOSIS
Rachel Gallant	621
A PROSPECTIVE PROTOCOL TO ASSESS RATES OF BACTERIAL RESISTANCE TO CEFTRIAXONE IN PEDIATRIC HEMATOLOGY-ONCOLOGY PATIENTS WITH FEBRILE NEUTROPENIA
Sophie Gatineau-Sailliant	711
IMPACT OF GENETIC POLYMORPHISMS DETERMINING LEUKOCYTE/NEUTROPHIL COUNT ON INDUCTION TOXICITY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A COMPLEMENTARY STUDY
Sophie Gatineau-Sailliant	760
LANGERHANS CELL HISTIOCYTOSIS WITH VERTEBRAL INVOLVEMENT DIAGNOSED IN A SINGLE CANADIAN PEDIATRIC ACADEMIC INSTITUTION
Jessica Geaney	619
REDUCTION IN RISK OF BACTEREMIA BASED ON RESPIRATORY PATHOGEN PANEL RESULTS
Jessica Geaney	755
IMPORTANCE OF UTILIZING MULTIPLE OBJECTIVE MEASURES OF ADHERENCE IN PEDIATRIC CANCER: COMPARISON BETWEEN PHARMACOLOGICAL ASSAYS AND BEHAVIORAL ADHERENCE
Erin Gelgoot	657
TRANSITION OF CARE FOR YOUNG ADULT SURVIVORS OF CHILDHOOD CANCER
Majd Ghanim	111
EXCEPTIONAL CLINICAL RESPONSE TO MOLECULAR GUIDED THERAPY IN A PATIENT WITH PROGRESSIVE LYMPHOEPITHELIOMA-LIKE THYMIC CARCINOMA
Majd Ghanim	058
SUCCESSFUL SUPPRESSION OF FACTOR VIII INHIBITOR TITERS WITH IMMUNE TOLERANCE INDUCTION IN AN INFANT WITH SEVERE HEMOPHILIA A DUE TO EXON DUPLICATION
Maurizio Ghisoli	811
TARGETING EWS-FLI1 DRIVING GENE: PRELIMINARY DATA OF PHASE 1 PBI-ShRNA EWS/FLI1 LIPOPLEX
Katrina Gleditsch	081
A NOVEL DE NOVO HETEROZYGOUS MUTATION IN THE PCDH17 GENE WITH MICROCEPHALY, DEVELOPMENTAL DELAY AND HISTORY OF ACUTE LYMPHOBLASTIC LEUKEMIA
Prabudh Goel	819
LAPAROSCOPIC MANAGEMENT OF INTRA - ABDOMINAL TUMORS - FEASIBLE OR NOT?
Alyssa Goodman	658
MEASURING LEVELS OF STRESS IN PARENTS OF CHILDREN WHO HAVE RECENTLY COMPLETED CANCER TREATMENT
Hamza Gorsi	004
A CASE REPORT OF SPONTANEOUS EXPECTORATION OF PULMONARY METASTASES IN A CHILD WITH OSTEOGENIC SARCOMA.
Hamza Gorsi	650
THE ASSOCIATION OF BLOCK GROUP POVERTY STATUS AND EXECUTIVE FUNCTIONING AMONG CHILDHOOD CANCER SURVIVORS
Nathan Gossai	732
BVGP: A NOVEL PROTOCOL FOR HODGKIN'S LYMPHOMA WITH EXCELLENT RESPONSE, MINIMAL ACUTE TOXICITIES AND REDUCED RISK OF LATE EFFECTS
Derrick Goubeaux	048
AN UNUSUAL ANAPHYLACTIC RESPONSE TO TREATMENT IN A PATIENT WITH SEVERE TYPE 1 VON WILLEBRAND DISEASE
Madhu Gowda	644
CANCER SURVIVORS WHO EXERCISE REGULARLY SEE IMPROVEMENTS IN PHYSICAL FITNESS EVEN WITHOUT WEIGHT LOSS.
Chandrika Gowda	704
UNDERSTANDING PEDIATRIC LEUKEMIA HEALTH DISPARITY: REGULATION OF CRLF2 BY IKAROS AND CASEIN KINASE II
Chandrika Gowda	716
ROLE OF RHO-GTPASE CDC42 IN LEUKEMIA AND ITS REGULATION BY IKAROS AND CASEIN KINASE II
Matthew Grant	063
USE OF EXTRACORPOREAL MEMBRANE OXYGENATION IN A PATIENT WITH NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA DESPITE COAGULOPATHY AND HEMORRHAGE
Katie Greenwood	023
DIAGNOSIS AND MANAGEMENT OF A NOVEL PHENOTYPE OF IMMUNODEFICIENCY, CENTROMERIC INSTABILITY, AND FACIAL ANOMALY SYNDROME (ICF) TYPE 4 WITH NEUTROPENIA AND NEUROBLASTOMA
Caroline Gross	769
DIVIDE AND CONQUER: EVALUATION OF A REDESIGN FOR INPATIENT PEDIATRIC ONCOLOGY SERVICE
Joanna Grossman Newton	526
CHANGING BLOOD CULTURE STRATEGY: A QUALITY IMPROVEMENT PROJECT TO ELIMINATE THE PRACTICE OF AUTOMATIC DAILY BLOOD CULTURES IN HOSPITALIZED PEDIATRIC PATIENTS WITH FEVER AND NEUTROPENIA
Liron Grossmann	332
VON WILLEBRAND FACTOR ANTIGEN AND MULTIMERS AS BIOMARKERS IN YOUNG PATIENTS WITH SICKLE CELL DISEASE
Liron Grossmann	911
HIGH INCIDENCE OF THROMBOTIC MICROANGIOPATHY IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS WITH MULTIPLE BLOODSTREAM INFECTIONS
Stephanie Gruner	079
PONATINIB USE IN PEDIATRIC/ADOLESCENT AND YOUNG ADULT PATIENTS WITH RELAPSED PH+ ALL: A CASE SERIES AND REVIEW OF THE LITERATURE
Arun Gurunathan	309
DELAYED OR INCORRECT DIAGNOSIS OF β-THALASSEMIA: α-GLOBIN GENE TRIPLICATION AS A COVERT GENETIC MODIFIER
Arun Gurunathan	817
CLINICAL UTILITY OF PET/CT IN PATIENTS WITH PIGMENTED VILLONODULAR SYNOVITIS TREATED WITH IMATINIB
Hadeel Halalsheh	813
THE ROLE OF ROUTINE IMAGING IN CHILDHOOD MELANOMA (MM)
Sarah Hall	413
EVALUATION OF THE HYPERMOBILE PATIENT IN BLEEDING DISORDERS CLINIC: REPORTS OF COMORBID EHLERS-DANLOS SYNDROME AND VON WILLEBRAND DISEASE
Katharine Halligan	050
USE OF ECULIZUMAB IN A PATIENT WITH REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA WITH HETEROZYGOUS NFKB1 MUTATION
Katharine Halligan	637
COMMUNICATION SKILLS TRAINING FOR PEDIATRIC RESIDENTS: LEARNING TO GIVE BAD NEWS
Tyler Hamby	729
PREVALENCE AND RISK FACTORS FOR MALNUTRITION DURING PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA INDUCTION THERAPY
Jennifer Han	032
THE COMBINATION OF SORAFENIB AND CAPECITABINE IN RECURRENT FIBROLAMELLAR HEPATOCELLULAR CARCINOMA: A NOVEL ORAL CHEMOTHERAPY APPROACH
Steven Hardy	341
A RANDOMIZED CONTROLLED TRIAL OF HOME-BASED COMPUTERIZED WORKING MEMORY TRAINING FOR CHILDREN WITH SICKLE CELL DISEASE
Steven Hardy	343
DISCRIMINATING CEREBRAL INFARCTS IN PEDIATRIC SICKLE CELL DISEASE USING BRIEF COMPUTERIZED NEUROCOGNITIVE ASSESSMENTS
Kip Hartman	008
DESMOPLASTIC SMALL ROUND CELL TUMOR OF THE CENTRAL NERVOUS SYSTEM
Susan Harvey	211
ESTABLISHING REFERENCE RANGES FOR COMPLETE BLOOD COUNTS IN CHILDREN WITH DOWN SYNDROME
Saman Hashmi	718
THE UNFOLDED PROTEIN RESPONSE AS A PREDICTOR OF CHEMOSENSITIVITY IN PEDIATRIC ACUTE MYELOID LEUKEMIA
Cassandra Hastings	638
HETEROGENEITY IN SCHOOL RE-ENTRY PROGRAMS FOR CHILDREN RETURNING TO SCHOOL FOLLOWING TREATMENT FOR CANCER
Jessica Heath	2022
TRANSCRIPTIONAL CO-REGULATION BY IKAROS AND RUNX1 IN MYELOID LEUKEMIA*
Jessica Heath	075
PROTRACTED ANAPHYLAXIS AFTER PEG-ASPARAGINASE: ACUTE MANAGEMENT AND SUBSEQUENT ASPARAGINASE TOLERANCE
Cristiana Hentea	034
GENETIC CHARACTERIZATION OF BILATERAL NEUROBLASTOMA USING WHOLE EXOME SEQUENCING
Cristiana Hentea	613
SOCIOECONOMIC IMPACT ON PARENTAL TREATMENT RATES OF PAIN AND NAUSEA
Sebastian Hesse	207
INTERROGATING THE HUMAN NEUTROPHIL GRANULOCYTE IN MONOGENIC DISEASE BY NEXT GENERATION PROTEOMICS
Kayeleigh Higgerson	832
CHARACTERIZATION OF LOCALIZED OSTEOSARCOMA OF THE EXTREMITY IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS FROM SOUTH TEXAS: INCREASING INSIGHT INTO HISPANIC POPULATIONS.
Kirsty Hillier	835
FACTORS IMPACTING TIME TO ENGRAFTMENT IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT
Jessica Hochberg	752
REDUCED BURDEN OF ONCOLOGIC THERAPY IN ADVANCED B-CELL LYMPHOMA IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH CD20+ MATURE B-CELL LYMPHOMA
Inga Hofmann	205
CONGENITAL THROMBOCYTOPENIA AND MYELOFIBROSIS DUE TO GERMLINE MUTATIONS IN G6B-B
Andrew Hong	803
IDENTIFYING MOLECULARLY DEFINED TARGETS IN HIGH RISK RENAL TUMORS FROM PATIENT DERIVED MODELS
Alex Hoover	108
SWEATING BLOOD: A CASE SERIES OF TWO SIBLINGS WITH HEMATOHIDROSIS
Amy Houghtelin	2006
EX VIVO EXPANDED MULTI-ANTIGEN SPECIFIC LYMPHOCYTES FOR THE TREATMENT OF SOLID TUMORS*
Frederick Huang	501
PARENTAL EDUCATION OF THE CENTRAL LINE CARE BUNDLE IS ASSOCIATED WITH A LOWER AMBULATORY CENTRAL LINE ASSOCIATED BLOODSTREAM INFECTION RATE
Ionela Iacobas	428
GUIDANCE DOCUMENT FOR HEPATIC HEMANGIOMA (INFANTILE AND CONGENITAL) EVALUATION AND MONITORING
Azada Ibrahimova	618
COMPARISON OF INPATIENT MORTALITY AND SUPPORTIVE CARE UTILIZATION IN INFANTS AND NON-INFANTS WITH ACUTE LEUKEMIA
Fiorella Iglesias	040
PRIMARY LEPTOMENINGEAL MEDULLOBLASTOMA: A RARE PRESENTATION OF MEDULLOBLASTOMA IN A CHILD
Noreen Islam	402
FACTOR XIIIA1 GENE VARIANTS IN THREE SIBLINGS WITH VARYING BLEEDING PHENOTYPES
Vishesh Jain	821
TREATMENT OUTCOMES OF MALIGNANT GERM CELL TUMOR: A SINGLE CENTRE EXPERIENCE OF 22 YEARS
Michael Jeng	758
LANGERHANS CELL HISTIOCYTOSIS: GASTROINTESTINAL INVOLVEMENT IN CHILDREN
Nina Kadan-Lottick	653
ASSOCIATION OF HEARING LOSS WITH COGNITIVE AND EMOTIONAL FUNCTIONING IN NON-CNS TUMOR CHILDHOOD CANCER SURVIVORS TREATED WITH PLATINUM-BASED CHEMOTHERAPY
Nina Kadan-Lottick	646
TELEPHONE COMMUNICATION BETWEEN NURSES AND PRIMARY CARE PHYSICIANS (PCPS) USING THE SITUATION, BACKGROUND, ASSESSMENT, AND RECOMMENDATION (SBAR) TOOL TO COORDINATE SURVIVORSHIP CARE: A FEASIBILITY STUDY
Meena Kadapakkam	839
B7-H3 CAR T CELLS MEDIATE IN VITRO AND IN VIVO ACTIVITY AGAINST NEUROBLASTOMA XENOGRAFTS
Alissa Kahn	052
AN UNLIKELY PRESENTATION OF A RARE COMBINATION: A CASE SERIES OF ALPHA GLOBIN GENE TRIPLICATION ASSOCIATED WITH BETA THALASSEMIA TRAIT IN HISPANIC PATIENTS
Julie Kanter Washko	203
CRIZANLIZUMAB 5.0 MG/KG INCREASED THE TIME TO FIRST ON-TREATMENT SICKLE CELL PAIN CRISIS (SCPC) AND THE LIKELIHOOD OF NOT EXPERIENCING SCPC WHILE ON TREATMENT: SUBGROUP ANALYSES OF THE PHASE 2 SUSTAIN STUDY
Julie Kanter Washko	503
RESULTS OF A NATIONAL PROVIDER SURVEY IN SICKLE CELL DISEASE MANAGEMENT
Julie Kanter Washko	601
QUALITY OF CARE IN US CHILDREN WITH SICKLE CELL DISEASE
Aroop Kar	738
BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION: A DISTINCT PATHOLOGIC AND CLINICAL ENTITY
Nicole Kendel	403
CHARACTERIZING ADOLESCENTS WITH HEAVY MENSTRUAL BLEEDING AND GENERALIZED JOINT HYPERMOBILITY
Paul Kent	009
SIADH DUE TO HIGH-DOSE METHOTREXATE
Paul Kent	762
LANGERHANS CELL HISTIOCYTOSIS THERAPY FOR THE TREATMENT OF LIFE-THREATENING ROSAI DORFMAN DISEASE
Jennifer Kesselheim	625
HUMANISM AND PROFESSIONALISM TRAINING IN PEDIATRIC HEMATOLOGY-ONCOLOGY FELLOWSHIP: RESULTS OF A MULTI-CENTER RANDOMIZED TRIAL
Dilruba Khanam	080
COMPLEXITY IN THE DIAGNOSIS OF MYOSIN HEAVY CHAIN 9-RELATED PLATELET DISORDER IN A PEDIATRIC PATIENT WITH ASYMPTOMATIC THROMBOCYTOPENIA
Kirshma Khemani	333
UNANTICIPATED CONSEQUENCES IDENTIFIED AFTER IMPLEMENTATION OF A PEDIATRIC EMERGENCY DEPARTMENT (PED)-BASED INTRANASAL FENTANYL (INF) PROTOCOL FOR THE TREATMENT OF VASO-OCCLUSIVE PAIN EPISODES (VOE) IN CHILDREN WITH SICKLE CELL DISEASE (SCD)
Ruby Khoury	915
ISLAM, THE QUR'AN, AND MEDICAL DECISION-MAKING – THE EXPERIENCE OF MIDDLE EASTERN MUSLIM FAMILIES WITH CHILDREN UNDERGOING STEM CELL TRANSPLANTATION IN THE UNITED STATES
Hiroto Kiguchi	629
BUILDING RESILIENCE DURING PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWSHIP: IMPLEMENTING SYSTEMATIC DEBRIEFING SESSIONS AND RESILIENCY CURRICULUM TO SUPPORT TRAINEES
Hyery Kim	807
THE EFFICACY OF INTENSIFIED ADJUVANT CHEMOTHERAPY IN OSTEOSARCOMA PATIENTS WITH METASTATIC DISEASE OR POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY
Trisha Kissoon	908
PARVOVIRUS B19 INFECTION MANIFESTING AS CYTOPENIA IN CONSTELLATION WITH BONE PAIN POST HEMATOPOIETIC STEM CELL TRANSPLANTATION
Jacquelyn Klicka-Skeels	344
CORRELATION BETWEEN HYDROXYUREA USE AND LEFT VENTRICULAR REMODELING AND FUNCTION IN CHILDREN WITH SICKLE CELL DISEASE
Tristan Knight	902
DIFFERING INCIDENCE AND PATTENRS OF CLOSTRIDIUM DIFFICILE INFECTION AMONG PEDIATRIC HEMATOLOGY, ONCOLOGY, AND HEMATOPOIETIC STEM CELL TRANSPLANTATION INPATIENT POPULATIONS
Melissa Knudson	336
EFFECT OF HYDROXYUREA AND CHRONIC PRBC TRANSFUSIONS ON PULMONARY FUNCTION DECLINE IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
Prachi Kothari	809
NONINVASIVE MOLECULAR PROFILING BY CIRCULATING CELL-FREE DNA IN PEDIATRIC SOLID TUMORS
Sara Kreimer	802
HDAC INHIBITION IN THALAMIC AND SPINAL CORD H3K27M+ DIFFUSE MIDLINE GLIOMA
Lakshmanan Krishnamurti	338
COMPARATIVE EFFECTIVENESS OF A PATIENT DECISION AID FOR THERAPEUTIC OPTIONS FOR SICKLE CELL DISEASE
Sairam Kumar	328
BIOMARKERS TO PREDICT SEVERITY OF SICKLE CELL VASO-OCCLUSIVE CRISIS IN THE PEDIATRIC AGE GROUP
Theodore Laetsch	703
TISAGENLECLEUCEL (CTL019) THERAPY APPEARS SAFE AND EFFECTIVE IN PEDIATRIC PATIENTS WITH DOWN SYNDROME WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA
Jessica Lake	016
A LOW-GRADE GLIOMA HISTOLOGICALLY DIAGNOSED AS AN EPENDYMOMA: HOW MOLECULAR DATA IS SHAPING THE WAY WE DIAGNOSIS AND TREAT BRAIN TUMORS
Samuele Renzi	036
EMBRYONAL RHABDOMYOSARCOMA SHOWING A NEW TRANSLOCATION (2:15): A CASE REPORT AND REVIEW OF THE LITERATURE
Benjamin Larsen	351
MANAGEMENT OF ACUTE SPLENIC SEQUESTRATION CRISIS: A CLINICAL PRACTICE SURVEY
Courtney Lawrence	401
CONTINUOUS ANTITHROMBIN INFUSION PROTOCOL TO OVERCOME HEPARIN RESISTANCE IN PEDIATRIC EXTRACORPOREAL MEMBRANE OXYGENATION: A SINGLE-CENTER EXPERIENCE
Zach Leblanc	901
PANETH CELL COUNTS INDEPENDENTLY PREDICT ACUTE GASTROINTESTINAL GVHD STAGE AND RESPONSE TO THERAPY
YoungNa Lee-Kim	505
STRATEGIES FOR IMPLEMENTING AN EFFECTIVE MORBIDITY, MORTALITY, AND IMPROVEMENT (MMI) CONFERENCE
Kathryn Lemberg	515
APPLICATION OF A HOSPITAL-WIDE BLOOD CULTURE CLINICAL DECISION ALGORITHM TO AN INPATIENT PEDIATRIC ONCOLOGY POPULATION: A FELLOW-LED QUALITY IMPROVEMENT PROJECT
Alicia Lenzen	808
IMMUNOTHERAPEUTIC NANOTECHNOLOGY TARGETING IDO1 FOR PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA
Yixian Li	104
A PATIENT WITH MACROCYTIC ANEMIA AND PLATELET DYSFUNCTION ASSOCIATED WITH A NOVEL VARIANT OF GATA1 MUTATION
Nicole Liberio	913
INVESTIGATING THE ROLE OF CELLULAR CONTENT AND GVHD IN DONOR LYMPHOCYTE INFUSIONS TO TREAT PEDIATRIC HEMATOLOGIC MALIGNANCIES: A SINGLE-CENTER LONG-TERM STUDY
Jaime Libes	025
PEDIATRIC USE OF A DENVER SHUNT: ANSWER TO A FAMILY’S GOALS OF CARE
Jaime Libes	057
ACHROMOBACTER XYLOSOXIDANS SEPTIC SHOCK: RARE CASE IN A PEDIATRIC PATIENT WITH RELAPSED NEUROBLASTOMA
Jaime Libes	097
PERITONEAL DISSEMINATION OF BRAF FUSION POSITIVE HIGH GRADE NEUROEPITHELIAL TUMORS IN A CHILD WITH A VENTRICULO-PERITONEAL SHUNT PLACED FOR A BRAF-FUSION POSITIVE LOW GRADE GLIOMA
Jaime Libes	107
MULTIVISCERAL ORGAN TRANSPLANTATION IN A 16-YEAR-OLD MALE WTH FIBROLAMELLAR HEPATOCELLULAR CARCINOMA
Amanda Lipsitt	007
A CLINICAL DESCRIPTION AND MEDICAL MANAGEMENT OF “STIGMATA”
Shi Lixiao	747
FUNCTION AND MECHANISM OF PI3K/AKT SIGNALING PATHWAY IN PEDIATRIC T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Michell Lozano Chinga	028
OCCURRENCE OF CUTANEOUS MYELOID SARCOMA IN A PATIENT WITH A HISTORY OF OVARIAN YOLK SAC TUMOR
Hannah Lust	095
CYTOKINE RELEASE SYNDROME AS A COMPLICATION OF SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA THERAPY
Hannah Lust	640
RETROSPECTIVE STUDY OF NEUROLOGIC, BEHAVIORAL, AND OPHTHALMOLOGIC SIDE EFFECTS OF DINUTUXIMAB THERAPY AT A SINGLE INSTITUTION
Megan Lyle	326
QUALITY IMPROVEMENT INITIATIVE TO INCREASE INCENTIVE SPIROMETRY USE IN HOSPITALIZED CHILDREN WITH SICKLE CELL DISEASE
Rebecca MacDonell-Yilmaz	444
MULTIFOCAL LYMPHANGIOENDOTHELIOMATOSIS WITH THROMBOCYTOPENIA: DIAGNOSIS AND TREATMENT OF AN INFANT WITH UNCOMMON FINDINGS OF A RARE DISORDER
Manasi Vivek Madiwale	652
YIELD OF SCREENING ECHOCARDIOGRAMS DURING TREATMENT AND IN THE EARLY POST-THERAPY PERIOD IN CHILDHOOD CANCER
Priya Mahajan	002
MAMMARY ANALOGUE SECRETORY CARCINOMA IN CHILDREN: A REPORT FROM THE TEXAS CHILDREN'S RARE TUMOR REGISTRY
Priya Mahajan	432
PEDIATRIC HEAD AND NECK LYMPHATIC MALFORMATIONS: PRENATAL PLANNING AND MANAGEMENT STRATEGIES IN THE MULTIMODAL ERA
Mona Mohamed Hamdy Mahmoud	214
ASSESSMENT OF QUALITY OF LIFE AMONG B -THALASSEMIA MAJOR PATIENTS AT A TERTIARY CARE HOSPITAL IN EGYPT
Mona Mohamed Hamdy Mahmoud	315
SERUM YKL-40 LEVEL IN PATIENTS WITH B-THALASSEMIA : RELATION TO VIRAL HEPATITIS, LIVER STIFNESS AND HEPATIC IRON CONCENTRATION
Robbie Majzner	2003
CAR T CELLS TARGETING B7-H3, A PAN-CANCER ANTIGEN, DEMONSTRATE POTENT PRECLINICAL ACTIVITY AGAINST PEDIATRIC SOLID TUMORS AND BRAIN TUMORS*
Kelly Maloney	2001
EXCELLENT EVENT-FREE (EFS) AND OVERALL SURVIVAL (OS) FOR CHILDREN WITH DOWN SYNDROME (DS) WITH STANDARD RISK B-ACUTE LYMPHOBLASTIC LEUKEMIA (SR B-ALL): RESULTS OF CHILDREN’S ONCOLOGY GROUP (COG) AALL0331*
Avani Mangoli	010
MALIGNANT DISSEMINATED GLIONEURONAL TUMOR WITH BRAF-KIAA1549 FUSION AND 1p DELETION RESPONDS TO MEK-INHIBITOR: A CASE REPORT
Ross Mangum	001
IDIOPATHIC HYPERAMMONEMIC ENCEPHALOPATHY: DIAGNOSTIC COMPLEXITIES AND MANAGEMENT OPTIONS
Jose Martinez	656
PROPHYLACTIC PLATELET TRANSFUSIONS WITH A ≤ 10 X 109/L THRESHOLD DOES NOT RESULT IN A HIGHER INCIDENCE OF BLEEDING EPISODES IN PEDIATRIC PATIENTS UNDERGOING CHEMOTHERAPY: A COHORT STUDY.
Colleen Mathews	073
VERY EARLY RELAPSE IN DS AML PATIENTS TREATED WITH A REDUCED DOSE ARA-C REGIMEN: A REPORT OF 2 CASES
Leonard Mattano	715
OSTEONECROSIS IS ASSOCIATED WITH IMPROVED EVENT FREE (EFS) AND OVERALL SURVIVAL (OS) IN HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA (HR-ALL): RESULTS OF CHILDREN’S ONCOLOGY GROUP (COG) STUDY AALL0232
Lisa Maurer	088
CONCURRENT LYME DISEASE SIGNIFICALLY IMPAIRS HEALING IN HEMOPHILIA HEMARTHROSIS
Jennifer Mayer	442
WHY WE SHOULD TREAT HEMANGIOMA-ASSOCIATED HYPOTHYROIDISM WITH TRIIODOTHYRONINE (T3)
Peter McCarthy	212
PREDICTORS OF RED BLOOD CELL TRANSFUSION, UNITS REQUIRED AND DONOR EXPOSURE IN LOW BIRTH WEIGHT INFANTS.
Sara McElroy	812
COMPARING THE NEUROCOGNITIVE FUNCTION AMONG PATIENTS WITH PEDIATRIC BRAIN TUMORS TREATED WITH PROTON VERSUS PHOTON RADIATION THERAPY
Thomas McLean	815
HYPOALBUMINEMIA IS NOT ASSOCIATED WITH INFERIOR SURVIVAL IN CHILDREN WITH CANCER
Jennifer McNeer	705
POOR OUTCOME FOR CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH HYPODIPLOID ALL IS NOT IMPROVED BY HEMATOPOIETIC STEM CELL TRANSPLANT: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)
Casey Mehrhoff	077
CLONE WARS: THE EMERGENCE OF A PHILADELPHIA-NEGATIVE CLONE IN A PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA RELAPSE
Casey Mehrhoff	062
CRITICALLY ILL 16-YEAR-OLD MALE WITH SEVERE IVIG-INDUCED COOMBS-POSITIVE HEMOLYTIC ANEMIA
Emily Meier	320
VACCINATION STATUS IS NOT CORRELATED WITH MORTALITY IN ADULTS WITH SICKLE CELL DISEASE
Emily Meier	603
A STEP ON THE PATH TO BUILDING A NOVEL TRANSITION PROGRAM: ONLINE LEARNING MODULES INCREASE FAMILY MEDICINE RESIDENTS' KNOWLEDGE ABOUT HYDROXYUREA AND COMPREHENSIVE CARE OF ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE BUT NOT TRANSITION BEST PRACTICES
Trevor Memmott	630
APPLICATION OF KDIGO GUIDELINES IN ASSESSING AKI IN PEDIATRIC PATIENTS NEWLY DIAGNOSED WITH ALL
Laurel Metzler	607
PROGNOSTIC GOALS OF CARE CONVERSATIONS FOR CRITICALLY ILL PEDIATRIC HEMATOLOGY/ONCOLOGY PATIENTS
Jennifer Michlitsch	076
VINCRISTINE-INDUCED ANEMIA IN HEREDITARY SPHEROCYTOSIS
Jonathan Miller	210
TWO CASES OF NEWLY DIAGNOSED MUSCULAR DYSTROPHY DISCOVERED IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA
Matthew Miller	706
COMBINATION OF KRAS MUTATION AND TET2 LOSS LEADS TO MYELOID SKEWING AND SYNERGISTIC ACTIVATION OF RAS SIGNALING IN A NOVEL MURINE MODEL
Lane Miller	724
INCIDENCE AND PREDICTORS OF RESPIRATORY ADVERSE EVENTS DURING INDUCTION THERAPY IN CHILDREN WITH ACUTE MYELOID LEUKEMIA
Katherine Minson	720
BONE MARROW STROMAL CELL MEDIATED RESISTANCE TO MERTK INHIBITION IN AML
Nupur Mittal	510
LOSS OF PROTECTIVE HUMORAL IMMUNITY AGAINST MEASLES IN PEDIATRIC ONCOLOGY PATIENTS: A RISK WITH THE RISE OF UNDERVACCINATION
Nupur Mittal	765
SINGLE INSTITUTION EXPERIENCE OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME ((PRES) ASSOCIATED WITH INDUCTION THERAPY FOR HIGH RISK PEDIATRIC ALL: IS THERE A ROLE OF PHARMACOETHNICITY
Scott Moerdler	219
DIFFERING PRENATAL HEMOGLOBINOPATHY SCREENING PRACTICES: HOW CAN THE PEDIATRIC HEMATOLOGIST INTERVENE?
Ashraf Mohamed	733
YOUNG AGE IS HIGHLY ASSOCIATED WITH MORNING HYPOGLYCEMIA AMONG CHILDREN RECEIVING ALL THERAPY
Ashraf Mohamed	767
PSYCHOSOCIAL AND PHYSICAL DISTRESS SCREENING: WHAT DO ADOLESCENTS AND YOUNG ADULTS ON CANCER THERAPY REPORT?
Ashraf Mohamed	702
SERUM CREATININE SIGNIFICANTLY UNDERESTIMATED THERAPY RELATED CHRONIC KIDNEY DISEASES AMONG CHILDHOOD CANCER PATIENTS
Kathleen Montgomery	663
PROSPECTIVE SYMPTOM ASSESSMENT IN CHILDREN WITH ADVANCED CANCER
Erin Morales	045
RECURRENT UNRESECTABLE CONGENITAL PARASPINAL PRIMITIVE MYXOID MESENCHYMAL TUMOR OF INFANCY: A CASE REPORT AND REVIEW OF THE LITERATURE
Daniel Moreira	631
REGIONAL IMPACT OF A PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWSHIP PROGRAM
Daniel Moreira	633
CREATION OF A STANDARDIZED ASSESSMENT TOOL FOR GLOBAL PEDIATRIC HEMATOLOGY/ONCOLOGY FELLOWSHIP PROGRAMS
Amy Moskop	112
EVANS SYNDROME, SYSTEMIC LUPUS ERYTHEMATOSUS, AND NEUROFIBROMATOSIS: AN UNUSUAL COMBINATION IN PEDIATRIC PATIENT
Amy Moskop	404
MECHANICAL HEMOLYSIS AND ACQUIRED TYPE 2A VONWILLEBRAND SYNDROME IN PATIENT WITH CONGENITAL HEART DISEASE
Michael Mowrer	043
AN ALK FUSION NOT PREVIOUSLY REPORTED IN REFRACTORY NEUROBLASTOMA
Michael Mowrer	766
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH HYPER IGE SYNDROME, PRESENTING TO THE PEDIATRIC INTENSIVE CARE UNIT WITH SEPSIS
Emily Mueller	620
SURVEY OF MOBILE TECHNOLOGY USAGE AND PERCEPTIONS BY CAREGIVERS OF CHILDREN WITH CANCER
Nicole Muhlbauer	015
SIGNIFICANT IMPROVEMENT IN PARANEOPLASTIC DYSAUTONOMIA WITH RITUXIMAB THERAPY
Jodi Muscal	044
SUCCESSFUL TREATMENT OF SARCOMA ARISING WITHIN ANAPLASTIC WILMS TUMOR AND THERAPY-RELATED IRON OVERLOAD WITH PHLEBOTOMY
Kasiani Myers	204
MDS AND AML IN SHWACHMAN DIAMOND SYNDROME: CLINICAL FEATURES AND OUTCOMES
Kalindi Narine	337
VALIDITY AND FEASIBILITY OF USING A MOBILE APPLICATION AND WEARABLE TECHNOLOGY FOR PATIENTS WITH SICKLE CELL DISEASE HOSPITALIZED FOR PAIN
Hanan Nazir	078
FRESH-FROZEN PLASMA TRANSFUSION FOR REPLACEMENT THERAPY IN A CHILD WITH HYPOPLASMINOGENEMIA AND LIGNEOUS CONJUNCTIVITIS: AN ALTERNATIVE OPTION TO DELAY RECURRENCE
Hanan Nazir	201
NEUTROPENIA AND LIFE THREATENING AGRANULOCYTOSIS AMONG CHILDREN WITH B THALASSEMIA TREATED WITH ORAL IRON CHELATORS IN A COMMUNITY WITH BACKGROUND OF ETHNIC NEUTROPENIA
Hanan Nazir	220
HERMANSKY- PUDLAK SYNDROME: SPECTRUM IN OMAN
Stephen Nelson	342
HYDROXYUREA USE IN INFANTS WITH SICKLE CELL DISEASE: THE EARLIER THE BETTER.
Adam Nelson	903
BUILDING A THIRD-PARTY VST BANK FROM SCRATCH- THE CINCINNATI EXPERIENCE
Adam Nelson	907
INCREASED CD34 CELL DOSE IS ASSOCIATED WITH RAPID IMMUNE RECONSTITUTION AFTER HSCT IN PATIENTS WITH FANCONI ANEMIA
Marie Laurence Noisette	206
CLINICAL OUTCOME OF FETUSES AND NEWBORNS WITH ALLOIMMUNIZATION WHO RECEIVED INTRAUTERINE TRANSFUSION
Dolly Noun	919
EARLY INFECTIOUS COMPLICATIONS FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR HIGH-RISK NEUROBLASTOMA: HIGH IMPACT ON MORTALITY AND MORBIDITY
Jamie Oakley	302
ACUTE KIDNEY INJURY DURING PARVOVIRUS B19-INDUCED TRANSIENT APLASTIC CRISIS IN SICKLE CELL DISEASE
Maureen O'Brien	728
RESULTS OF A PHASE 2, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY OF LENALIDOMIDE IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
Nancy Olivieri	216
EVALUATION OF QUALITY OF LIFE IN SRI LANKAN PATIENTS WITH THALASSEMIA
Nancy Olivieri	303
TWENTY-YEAR FOLLOW-UP OF PATIENTS WITH HEMOGLOBIN E THALASSEMIA IN SRI LANKA
Nancy Olivieri	307
EXPERIENCE WITH THE IRON-CHELATOR DEFERASIROX IN SRI LANKAN PATIENTS WITH THALASSEMIA
Nancy Olivieri	317
EVALUATION OF CLINICAL AND LABORATORY FINDINGS IN PATIENTS WITH HEMOGLOBIN E BETA THALASSEMIA IN A SINGLE CENTER IN KOLKATA, INDIA
Andrea Orsey	610
USE OF AN INSTITUTIONAL-TREATMENT ALGORITHM TO IMPROVE THE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV)
Daniel Ortiz	355
PREVALENCE OF VITAMIN D DEFICIENCY AMONG CHILDREN AND YOUNG ADULTS WITH SICKLE CELL DISEASE AND ITS RELATIONSHIP WITH DISEASE SEVERITY
RebeccaOrtolano	084
NOVEL SAMD9L MUTATION IN A PATIENT WITH PANCYTOPENIA, IMMUNE DYSFUNCTION, AND MONOSOMY 7 MYELODYSPLASTIC SYNDROME
Christopher Ours	013
UNIQUE PRESENTATIONS OF ATAXIA-TELANGIECTASIA IN TWO BROTHERS
Joseph Oved	2010
OUTCOMES OF UNRELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION FOR PATIENTS WITH NON-MALIGNANT HEMATOLOGIC DISORDERS USING TWO PARTIAL T CELL DEPLETION STRATEGIES*
Holly Pacenta	713
IDENTIFICATION OF NOVEL THERAPEUTIC TARGETS IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA
Ruzanna Papyan	648
THE STATE OF PEDIATRIC ONCOLOGY IN ARMENIA: CHALLENGES AND ACHIEVEMENTS
Robin Parihar	2004
NATURAL KILLER CELLS TARGETING THE SUPPRESSIVE IMMUNE MICROENVIRONMENT OF PEDIATRIC SOLID TUMORS RESCUE THE IMPAIRED ACTIVITY OF CAR-T CELLS*
Priyal Patel	003
A RARE CASE OF IMMUNODEFICIENCY, CENTROMERE INSTABILITY, AND FACIAL ANOMALIES TYPE I SYNDROME IN A MALE INFANT
Krupesh Patel	011
WOLMAN DISEASE AND HLH, A CASE OF OVERLAPPING CLINICAL FEATURES
Krupesh Patel	109
A CASE FOR EARLY DABRAFENIB USE IN PATIENTS WITH BRAF V600E POSITIVE LOW GRADE GLIOMAS
Megan Paul	041
PRIMARY MULTIFOCAL INTRACEREBRAL EXTRAOSSEUS OSTEOSARCOMA WITH AGGRESSIVE CLINICAL COURSE IN A PATIENT WITH LOBAR HOLOPROSCENCEPHALY
Megan Paul	113
BONE METASTASES IN PEDIATRIC HIGH GRADE GLIOMA: A CASE SERIES AND REVIEW OF THE LITERATURE
Megan Paul	806
THE ROLE OF G-CSF RECEPTOR SURFACE EXPRESSION IN MEDULLOBLASTOMA PATHOGENESIS
Anjali Pawar	441
A PILOT STUDY OF SOCIAL AND ACADEMIC IMPLICATIONS OF HEAVY MENSTRUAL BLEEDING IN ADOLESCENT AND YOUNG ADULT FEMALES
Kimberly Payne	2023
NOVEL BIOLOGIC FOR THE TREATMENT OF PH-LIKE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH OVER EXPRESSION OF CRLF2*
Scott Penney	033
LONG TERM REMISSION WITH SIROLIMUS FOR A PEDIATRIC PATIENT WITH AN EBV-ASSOCIATED SMOOTH MUSCLE TUMOR AFTER BONE MARROW TRANSPLANTATION
Robin Pham	005
MUTATION OF CEP72 GENE MAY PREDISPOSE PATIENTS TO HEPATOTOXICITY
Rachel Phelan	642
A STANDARDIZED APPROACH USING PHLEBOTOMY TO TREAT TRANSFUSIONAL IRON OVERLOAD IN PEDIATRIC AND YOUNG ADULT ONCOLOGY PATIENTS
Lia Phillips	059
ALLOPURINOL USE WITH 6-MERCAPTOPURINE IN MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
Navin Pinto	820
PATTERNS OF EXPRESSION OF DISIALOGANGLIOSIDE GD2 IN PEDIATRIC SARCOMAS
Lauren Pommert	101
PRIMARY EXTRARENAL WILMS TUMOR OF THE TESTIS
Samara Potter	012
PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Jacquelyn Powers	2011
CAREGIVER PERCEPTIONS OF IRON DEFICIENCY ANEMIA AND IRON REPLACEMENT THERAPIES IN YOUNG CHILDREN WITH NUTRITIONAL IRON DEFICIENCY ANEMIA*
Pinki Prasad	609
MONOCLONAL ANTIBODY UTILIZATION IN ADOLESCENTS AND YOUNG ADULTS: A POPULATION BASED STUDY
Suraj Pratap	712
GENERATION AND CHARACTERIZATION OF FLT3 LIGAND-CONTAINING CHIMERIC ANTIGEN RECEPTOR (CAR) T-LYMPHOCYTES
Zachary Prudowsky	514
ASSESSING RISK OF HOSPITAL-ACQUIRED PEDIATRIC VENOUS THROMBOEMBOLISM USING A NOVEL SCORING SYSTEM
Geetha Puthenveetil	436
MULTIDISCIPLINARY APPROACH TO TREATMENT OF VASCULAR MALFORMATIONS - A SINGLE INSTITUTION EXPERIENCE
Charles Quinn	2009
NEUROPROTECTIVE EFFECTS OF HYDROXYUREA IN SICKLE CELL ANEMIA: MAINTENANCE OF NORMAL CEREBRAL OXYGENATION*
Charles Quinn	319
EARLY INITIATION OF DISEASE-MODIFYING THERAPY PREVENTS DIFFUSE MYOCARDIAL FIBROSIS IN SICKLE CELL ANEMIA
Venkatraman Radhakrishnan	508
EFFICACY OF SINGLE DOSE RASBURICASE (1.5 MG) FOR PROPHYLAXIS AND MANAGEMENT OF TUMOR LYSIS SYNDROME
Elizabeth Raetz	725
CONTINUED IMPROVEMENTS IN OVERALL SURVIVAL (OS) IN CHILDREN WITH NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A CHILDREN’S ONCOLOGY GROUP (COG) REPORT
Saman Raftari	730
FREQUENCY OF 17P ABNORMALITIES IN IRANIAN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) .
Nora Rahmani	768
SINUS HISTIOCYTOSIS WITH MASSIVE LYMPHADENOPATHY: CASE SERIES AND LITERATURE REVIEW TO HIGHLIGHT TREATMENT OPTIONS
Sandhya Rajan	606
METABOLIC SYNDROME IN CHILDHOOD CANCER SURVIVORS IN SOUTH INDIA
Archana Ramgopal	405
CENTRAL LINE-RELATED DEEP VEIN THROMBI IN CHILDREN: A CLEVELAND CLINIC EXPERIENCE
Lauren Raney	507
KNOWLEDGE OF AND ATTITUDES TOWARDS HPV VACCINE IN PREADOLESCENTS AND TEENS
Andrew Rankin	801
LANDSCAPE OF TARGETABLE BRAF ALTERATIONS AND RAF1 FUSIONS IN PEDIATRIC MALIGNANCY
Wafaa Rashed	660
SECOND TUMOR IN THYROID CANCER PEDIATRIC SURVIVORS
Scott Raskin	823
AN UNUSUAL CASE PRESENTATION OF A SEX CORD STROMAL TUMOR IN A 3 MONTH OLD INFANT
Yaddanapudi Ravindranath	410
MANAGEMENT OF BUDD CHIARI SYNDROME IN CHILDREN
Kiranmye Reddy	098
17 YEAR OLD FEMALE WITH POLYCYTHEMIA SECONDARY TO A HIGH OXYGEN AFFINITY HEMOGLOBINOPATHY
Ariel Reinish	312
ADDRESSING THE EDUCATIONAL NEEDS OF ADOLESCENTS AND YOUNG ADULTS WITH SICKLE CELL DISEASE AS THEY TRANSITION TO THE ADULT HEALTHCARE SYSTEM: A PILOT STUDY
Allison Remiker	2025
MECHANISMS LINKING FIBRIN(OGEN) STRUCTURE/FUNCTION TO TUMOR METASTASIS*
Allison Remiker	072
SUCCESSFUL TREATMENT WITH MYCOPHENOLATE MOFETIL IN SEVERE HEMOPHILIA A COMPLICATED BY HIGH TITER INHIBITOR: A CASE REPORT
Jennifer Rohan	759
ELECTRONIC MONITORING OF MEDICATION ADHERENCE DURING MAINTENANCE PHASE THERAPY FOR PEDIATRIC CANCER: BEHAVIORAL ADHERENCE PATTERNS
Jenna Rossoff	617
COST ANALYSIS OF BRONCHOALVEOLAR LAVAGE AND RESPIRATORY TRACT BIOPSIES IN THE DIAGNOSIS AND MANAGEMENT OF SUSPECTED INVASIVE FUNGAL INFECTION
Seth Rotz	757
LONG-TERM OUTCOMES IN PEDIATRIC HEART TRANSPLANTATION RECIPIENTS WITH SECONDARY MALIGNANCY: A SINGLE INSTITUTION STUDY
Seth Rotz	909
SCREENING ECHOCARDIOGRAPH MAY NOT BE NECESSARY IN A SUBSET OF LONG-TERM SURVIVORS OF PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Jennifer Ruiz	055
ACUTE LYMPHOBLASTIC LEUKEMIA IN PEDIATRIC GM1 GANGLIOSIDE TYPE 1
Melisa Ruiz-Gutierrez	2002
INDUCED PLURIPOTENT STEM CELL MODEL OF 7Q DELETION IN BONE MARROW FAILURE IDENTIFIES A NOVEL THERAPEUTIC STRATEGY*
Daniel Runco	655
IMPACT OF TUMOR TYPE AND TREATMENT INTENSITY ON WEIGHT-FOR-AGE THROUGH CANCER THERAPY IN CHILDREN LESS THAN 3 YEARS OLD
Katherine Ryan	064
A RARE CASE OF PRIMARY POLYCYTHEMIA VERA IN A PEDIATRIC PATIENT
Anthony Sabulski	714
A PEDIATRIC LEUKEMIA PATIENT-DERIVED XENOGRAFT SYSTEM FOR PRE-CLINICAL TESTING OF THERAPEUTIC TARGETS IDENTIFIED BY NEXT-GENERATION SEQUENCING
Yasim Saied	100
A CONDITION OF MULTIPLE ORIFICE BLEEDING IN ABSENCE OF COAGULATION OR PLATELETS DEFECTS.
Gabriel Salinas Cisneros	763
OUTCOMES AND CHOICES OF PLACEMENT OF CENTRAL VENOUS ACCESS IN PATIENTS WITH A NEW DIAGNOSIS OF LEUKEMIA
Pranav Santapuram	616
HEALTH OUTCOMES IN CONTEMPORARY SURVIVORS OF PEDIATRIC HODGKIN LYMPHOMA
Amanda Saraf	612
EXAMINING PREDICTORS AND OUTCOMES OF FERTILITY CONSULTS AMONG CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH CANCER
Alexandra Satty	917
THE ROLE OF TONSILLECTOMY IN PATIENTS WITH LOCALIZED EPSTEIN-BARR VIRUS-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Kay Saving	308
QUALITY IMPROVEMENT FOR UREA ADHERENCE IN KIDS WITH SICKLE CELL DISEASE (QUAKS)
Kay Saving	348
ADVANTAGES OF USING QUALITY IMPROVEMENT (QI) PROCESSES TO IMPROVE THE CARE OF A SICKLE CELL POPULATION
Matthew Schefft	318
IMPACT OF PCR-BASED VIRAL PANELS ON CARE FOR FEBRILE CHILDREN WITH SICKLE CELL DISEASE
Lauren Scherer	356
A CASE OF SEVERE EBV VIREMIA PRESENTING WITH HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH UNDIAGNOSED SICKLE CELL ANEMIA
Deborah Schiff	085
SUCCESSFUL TREATMENT WITH BORTEZOMIB, PANOBINOSTAT, AND DEXAMETHASONE OF ACUTE MYELOID LEUKEMIA (AML) IN 2ND RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) : THERAPY SELECTED BASED UPON RESULTS OF A PERSONALIZED FLOW CYTOMETRIC SCREEN FOR DRUG SENSITIVITY
Wade Schulz	433
TRANSFUSION OF PATHOGEN-REDUCED (PR) SINGLE DONOR PLATELETS (SDP) TO THROMBOCYTOPENIC NEONATES AND PEDIATRIC PATIENTS: EVALUATION OF PLATELET USAGE AND TRANSFUSION REACTIONS (TR)
Jessica Seaborn	513
IMPROVING HOSPITAL PRACTICES FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH EARLY PROPHYLACTIC USE OF OLANZAPINE IN CHILDREN WITH CANCER
Laura Sedig	622
BEREAVED PARENT PERSPECTIVES ON END OF LIFE CARE FOR PEDIATRIC ONCOLOGY PATIENTS
Catherine Segbefia	312
PUBERTAL CHANGES IN CHILDREN WITH SICKLE CELL DISEASE AT KORLE BU TEACHING HOSPITAL, ACCRA, GHANA
Tyler Severance	912
GRANULOCYTE TRANSFUSIONS IN PEDIATRIC PATIENTS WITH NEUTROPENIA: ASSESSING EFFICACY AND OUTCOMES FOLLOWING THE USE OF A LOCAL GRANULOCYTE DONOR PROGRAM
Nidhi Shah	068
DIFFERENTIATING ATYPICAL HEMOLYTIC UREMIC SYNDROME VERSUS AUTOIMMUNE HEMOLYTIC ANEMIA: MANAGEMENT OF PATIENTS IN EXTREMIS
Sanam Shahid	037
IATROGENIC IMMUNODEFICIENCY-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER IN A CHILD WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Mark Shamoun	089
LONG TERM REMISSION WITH TOPOTECAN, VINORELBINE, THIOTEPA, AND CLOFARABINE (TVTC) FOR RE-INDUCTION FOLLOWED BY MAINTENANCE THERAPY WITH VENETOCLAX IN A YOUNG ADULT PATIENT WITH AML THAT RELAPSED POST TRANSPLANT.
Margaret Shatara	701
HEMOGLOBIN AND PLATELET THRESHOLDS FOR RED BLOOD CEEL AND PLATELET TRANSFUSIONS IN CHILDREN UNDERGOING TREATMENT FOR ONCOLOGIC DISEASES
Jenny Shim	831
TARGETING THE YES-ASSOCIATED PROTEIN IN NEUROBLASTOMA
Giselle Sholler	805
A BEAT CHILDHOOD CANCER PILOT STUDY FOR HIGH RISK NEUROBLASTOMA AT DIAGNOSIS WITH MOLECULAR GUIDED THERAPY AND EXTENDED MAINTENANCE WITH DFMO
Iman Sidhom	723
IMPACT OF MINIMAL RESIDUAL DISEASE ON OUTCOME OF CHILDREN WITH HYPODIPLOID ACUTE LYMPHOBLASTIC LEUKEMIA
David Siegel	605
INCIDENCE RATES AND TRENDS OF PEDIATRIC CANCER — UNITED STATES, 2001–2014
Debra Simon	049
METASTATIC NEUROENDOCRINE CARCINOMA RESPONDING TO MEK INHIBITION
Luke Smart	335
GEOSPATIAL MAPPING OF SICKLE CELL DISEASE IN NORTHWESTERN TANZANIA
Valeria Smith	017
EXPLORING WHY PEDIATRIC CANCER PATIENTS ARE DYING IN THE INTENSIVE CARE UNIT WITH LONGSTANDING DO NOT RESUSCITATE ORDERS
Valeria Smith	035
EXPLORING WHY PEDIATRIC CANCER PATIENTS ARE DYING IN THE INTENSIVE CARE UNIT WITH LONGSTANDING DO NOT RESUSCITATE ORDERS
Christine Smith	218
THROMBOCYTOPENIA IN THE SETTING OF MENORRHAGIA-INDUCED IRON DEFICIENCY ANEMIA: A SERIES OF THREE CASES
Christine Smith	634
ADAPTATION OF CANCER CENTER SURVIVORSHIP CARE PLAN GUIDELINES IN THE PEDIATRIC ONCOLOGY POPULATION
Wesley Smith	719
EVALUATION OF CHEST X-RAYS AND THE ASSOCIATED CLINICAL COURSE FOR CHILDREN WITH NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA
Jennifer Snaman	522
INCORPORATING BEREAVED PARENTS AS FACULTY FACILITATORS AND EDUCATORS IN TEACHING PRINCIPLES OF PALLIATIVE AND END-OF-LIFE CARE TO ONCOLOGY PROVIDERS
Jennifer Snaman	627
COMMUNICATION TRAINING EXPERIENCE AND NEEDS ASSESSMENT FOR FELLOWS IN PEDIATRIC HEMATOLOGY-ONCOLOGY
Stacy Snyder	019
ATAXIA TELANGIECTASIA PRESENTING WITH SEVERE NEUTROPENIA AND INVASIVE ACTINOMYCES INFECTION.
Amy Sobota	304
SCREENING FOR SOCIAL DETERMINANTS OF HEALTH IN AN URBAN PEDIATRIC SICKLE CELL DISEASE CLINIC: A QUALITY IMPROVEMENT INITIATIVE
Amy Sobota	306
DISPENSING LIQUID HYDROXYUREA TO PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: A NOVEL INSTITUTIONAL APPROACH TO REDUCING BARRIERS TO ADHERANCE
Elizabeth Sokol	837
PROGNOSTIC SIGNIFICANCE OF METASTATIC MIBG-POSITIVE DISEASE SITES AT DIAGNOSIS IN HIGH-RISK NEUROBLASTOMA PATIENTS
Heather Soni	408
INTERNATIONAL NORMALIZED RATIO (INR) DOCUMENTATION OPTIMIZATION: A CLINICAL AND INFORMATICS COLLABORATIVE APPROACH
Caryn Sorge	093
COMMON VIRUS OR RETURN OF MALIGNANCY? ADENOVIRUS IN A PATIENT WITH BURKITT LYMPHOMA
Emily Southard	213
THE EMERGING ROLE OF MECOM MUTATIONS IN PEDIATRIC BONE MARROW FAILURE: A CASE SERIES
Philippa Sprinz	314
THE CLINICAL COURSE OF CHILDREN AND YOUNG ADULTS WITH SICKLE CELL DISEASE IN NORTHERN HAITI TREATED WITH PENICILLIN AND HYDROXYUREA
Meera Srikanthan	018
A CASE OF RUBINSTEIN-TAYBI SYNDROME PRESENTING WITH NEUROBLASTOMA AND MALIGNANT HYPERTENSION
Anand Srinivasan	069
IDH1 MUTATED ACUTE MYELOID LEUKEMIA IN A CHILD WITH METAPHYSEAL CHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA
Anand Srinivasan	083
MYELOID NEOPLASMS ASSOCIATED WITH EOSINOPHILIA: A RARE PEDIATRIC ENTITY
David Stammers	434
A FIBRO-ADIPOSE VASCULAR ANOMALY MASQUERADING AS AN INTRAMUSCULAR HEMATOMA IN THE SETTING OF IMMUNE THROMBOCYTOPENIA
Claire Stokes	521
REDUCING LENGTH OF STAY OF HIGH-DOSE METHOTREXATE ADMISSIONS
Brian Stover	810
PERSONALIZED RNA-NANOPARTICLE VACCINES TARGETING OSTEOSARCOMA
Austin Stuckert	721
USE OF ALLOPURINOL TO REDIRECT 6-MERCAPTOPURINE METABOLISM IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Jacqueline Sun	417
COMPARISON OF BODY MASS INDEX AND JOINT HEALTH OUTCOMES IN PEDIATRIC HEMOPHILIA A PATIENTS
Neeraja Swaminathan	030
MUCOEPIDERMOID CARCINOMA: CASE REPORT AND ANALYSIS OF MECT1-MAML2 FUSION TRANSCRIPT IN CASES FROM IOWA
Takuto Takahashi	345
RISK FACTORS FOR RESPIRATORY FAILURE AMONG PEDIATRIC ACUTE CHEST SYNDROME IN SICKLE CELL DISEASE
Ravi Talati	668
CAN PICC LINE ASSOCIATED VENOUSTHROMBOEMBOLISM BE PREVENTED BY EARLY REMOVAL?
David Taylor	407
LACK OF CORRELATION BETWEEN BLEEDING SCORES AND PLATELET ELECTRON MICROSCOPY IN DELTA-GRANULE STORAGE POOL DISORDER
Aravind Thavamani	347
MEAN PLATELET VOLUME IN SICKLE CELL DISEASE PREDICTS MORTALITY AND DISEASE SEVERITY
Lincy Thomas	042
DIFFUSE MIDLINE GLIOMA, H3K27M-MUTANT TUMOR WITH IMMUNOHISTOCHEMISTRY DIFFUSELY POSITIVE FOR SYNAPTOPHYSIN AND NEGATIVE FOR GFAP
William Thomsen	022
DESCRIPTION OF A NOVEL BRAF MUTATION IN CHILD WITH FIBROUS HAMARTOMA OF INFANCY
Karen Thudium Mueller	707
IMPACT OF HUMORAL IMMUNOGENICITY (ANTI-MCAR19 ANTIBODIES) ON TISAGENLECLEUCEL (CTL019) CELLULAR KINETICS, EFFICACY, AND SAFETY
Margaret Tonda	301
INITIAL RESULTS FROM A COHORT IN A PHASE 2A STUDY (GBT440-007) EVALUATING ADOLESCENTS WITH SICKLE CELL DISEASE TREATED WITH MULTIPLE DOSES OF VOXELOTOR, A SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR
Margaret Tonda	352
NOVEL TRIAL DESIGN TO EVALUATE ORAL VOXELOTOR FOR THE TREATMENT OF SICKLE CELL DISEASE: PROTOCOL OF THE PHASE 3 HEMOGLOBIN OXYGEN AFFINITY MODULATION TO INHIBIT SICKLE HEMOGLOBIN POLYMERIZATION (HOPE) TRIAL (GBT440-031)
Carlos Torres	628
'THEY HELP WEAVE IT ALL TOGETHER': STAFF IMPACT ON BEREAVED PARENTS' GRIEF AFTER THEIR CHILD DIES OF CANCER
Adriana Trabal	027
SINUSOIDAL OBSTRUCTION SYNDROME AND SUSCEPTIBILITY TO BLEEDING AFTER GASTRIC TUBE PLACEMENT
Adriana Traba	103
TRABECTEDIN RESPONSE IN REFRACTORY METASTATIC SYNOVIAL SARCOMA
Cameron Trenor	2026
SAFETY AND PATIENT-REPORTED EFFICACY OF SIROLIMUS IN 120 PATIENTS WITH VASCULAR ANOMALIES: A REPORT FROM THE LYMPHATIC ANOMALIES REGISTRY*
Cameron Trenor	426
SIROLIMUS FOR REFRACTORY FIBROADIPOSE VASCULAR ANOMALY
Erin Trovillion	905
RESTORATION OF CD4+FOXP3+ REGULATORY T CELLS AND PROTECTION FROM CHRONIC GRAFT VERSUS HOST DISEASE IN PEDIATRIC TRANSPLANT PATIENTS DEPENDS ON EFFECTIVE POST-TRANSPLANT THYMOPOIESIS
Luci Turcotte	065
SYNCHRONOUS HEMATOLOGIC MALIGNANCIES: CONCURRENT SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA AND B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN A PEDIATRIC PATIENT
Elizabeth Ulm	756
DISEASE-CAUSING COPY NUMBER VARIANTS IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS DISEASE GENES
Ramya Uppuluri	906
HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE IN BENIGN HEMATOLOGICAL DISORDERS – COST EFFECTIVE CURE FOR CHILDREN IN INDIA
Sarah R. Vaiselbuh	743
EXOSOMAL MICRO RNA-181a INHIBITION CURBS LEUKEMIC PROLIFERATION IN PEDIATRIC ALL.
Kristen VanHeyst	836
TARGETING VCAM-1/α4β1 SIGNALING TO AMELIORATE PULMONARY METASTATIC OSTEOSARCOMA
Liliana Vasquez	632
FACTORS ASSOCIATED WITH ABANDONMENT OF PEDIATRIC CANCER TREATMENT IN PERU: A MULTICENTER COHORT STUDY
Jacqueline Vaughn	910
FEASIBILITY AND ACCEPTABILITY OF USING A MOBILE APP AND WEARABLE FOR PATIENTS UNDERGOING PEDIATRIC BLOOD AND MARROW TRANSPLANT
Saranya Veluswamy	327
COLD PAIN CAUSES GREATER VASOCONSTRICTION IN SICKLE CELL DISEASE SUBJECTS AND NORMAL CONTROLS EXPOSED TO GRADED THERMAL STIMULI
Rajkumar Venkatramani	834
UTILITY OF GALLIUM 68 DOTATATE PET/CT SCAN IN PEDIATRIC NEUROENDOCRINE TUMORS: A REPORT FROM TEXAS CHILDREN’S RARE TUMOR REGISTRY
Gabriela Villanueva	741
A STUDY OF THE ASSOCIATION BETWEEN CYTOGENETICS, RACE AND ETHNICITY AMONG PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AT THE UNIVERSITY OF CHICAGO
Shelton Viola	710
A NOVEL METHOD OF ISOLATING PRIMARY BONE MARROW MESENCHYMAL STEM AND STROMAL CELLS IN LEUKEMIA
Cielle Wachnian	359
COLD EXTERNAL TEMPERATURES AND SICKLE CELL MORBIDITY IN CHILDREN: A RETROSPECTIVE ANALYSIS
Yuexi Wang	322
CLINICAL BURDEN AND MANAGEMENT OF SICKLE CELL DISEASE AMONG PEDIATRIC PATIENTS
Russell Ware	323
NOVEL USE OF HYDROXYUREA IN AN AFRICAN REGION WITH MALARIA (NOHARM): YEAR 2 FINAL RESULTS
Russell Ware	325
NOVEL USE OF HYDROXYUREA IN AN AFRICAN REGION WITH MALARIA: EFFECTS OF HYDROXYUREA TREATMENT ON TRANSCRANIAL DOPPLER (TCD) VELOCITIES
Russell Ware	349
STROKE AVOIDANCE FOR CHILDREN IN REPUBLICA DOMINICANA (SACRED)
Carla Washington	305
THE PHARMACOKINETICS OF VOXELOTOR FOLLOWING SINGLE DOSES IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE
Jennifer Webb	518
QUALITY IMPROVEMENT: TEXT-BASED APPOINTMENT REMINDERS FAIL TO IMPROVE RATES OF MISSED TRANSFUSION APPOINTMENTS
Mary Frances Wedekind	838
INCREASED ANTITUMOR EFFICACY OF PD-1 BLOCKADE COMBINED WITH ONCOLYTIC HERPES VIROTHERAPY IN MURINE OSTEOSARCOMA IS DUE TO INCREASED CD8+/TREG RATIO
Rebecca Weicht	840
POLYAMINE BIOSYNTHETIC PATHWAY AS A DRUG TARGET FOR OSTEOSARCOMA THERAPY
Julie Weisman	2027
PERIPHERAL ARTERIAL THROMBOSIS IN HOSPITALIZED CHILDREN: CHARACTERISTICS AND SHORT-TERM OUTCOMES OF EXTENDED ANTICOAGULATION*
Laura Wheaton	734
PREGNANCY TESTING AND CONTRACEPTIVE COUNSELING IN FEMALES WITH NEWLY DIAGNOSED HODGKIN LYMPHOMA: EXPERIENCE AT A PEDIATRIC CENTER
Shanna White	726
CHEST X-RAY FINDINGS IN NEWLY DIAGNOSED PEDIATRIC ACUTE MYELOID LEUKEMIA
Andrea Whitfield	094
A CHALLENGING CASE OF HEPARIN INDUCED THROMBOCYTOPENIA IN A CRITICALLY ILL PEDIATRIC PATIENT AND NEED FOR ALTERNATIVE ANTI-COAGULATION
Brittney Whitford	517
HELPING OUR PEERS ENDURE STRESS (HOPES) – A PEER SUPPORT INITIATIVE IN PEDIATRIC HEMATOLOGY / ONCOLOGY
Sarah Whittle	647
PEDIATRIC CANCER HOSPITALIZATIONS PAID FOR BY MEDICAID ARE LONGER THAN THOSE PAID FOR BY COMMERCIAL INSURANCE
Hope Wilson	411
UTILITY OF PLATELET AGGREGATION TESTING AS A DIAGNOSTIC TOOL IN PEDIATRIC PATIENTS WITH BLEEDING PROBLEMS
Katrina Winsnes	615
DELIRIUM: A PROSPECTIVE STUDY WITHIN THE PEDIATRIC HEMATOLOGY, ONCOLOGY, AND BONE MARROW TRANSPLANT (PHO) POPULATION AT A SINGLE INSTITUTION
Nicole Wood	509
STANDARDIZING MEDICATION RECONCILIATION FOR A SAFE AND SUCCESSFUL DISCHARGE HOME IN NEWLY DIAGNOSED PEDIATRIC ONCOLOGY PATIENTS
Erin Wright	106
MANAGEMENT OF BLEEDING IN A PATIENT WITH JUVENILE DERMATOMYOSITIS AND UNRESPONSIVE IMMUNE THROMBOCYTOPENIA
Erin Wright	904
SUCCESSFUL USE OF BASILIXIMAB IN THE TREATMENT OF STEROID REFRACTORY GRAFT VERSUS HOST DISEASE IN A TWO YEAR OLD FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANT
Natalie Wu	524
OUTCOMES OF OBSERVATION WITHOUT EMPIRIC IV ANTIBIOTICS IN FEBRILE, NON-NEUTROPENIC PEDIATRIC ONCOLOGY PATIENTS
Jade Wulff	828
TARGETING INTEGRIN-MEDIATED SIGNALING IN METASTATIC EWING SARCOMA
Nathan Yarnall	731
HEPATOTOXICITY REQUIRING LIVER BIOPSY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
David Young	2024
UNIVERSAL PRETREATMENT FOR ASPARAGINASE-BASED THERAPY SHOULD BE STANDARD OF CARE*
Lindsey Young	502
CHEMOTHERAPY INDUCED NAUSEA VOMITING: NURSING ASSESSMENT AND UTILITY OF THE BAXTER RETCHING FACES (BARF) NAUSEA SCALE
Ahmar Zaidi	331
IDENTIFYING AND ASSESSING AT-HOME VASO-OCCLUSIVE CRISES (VOC) IN PATIENTS WITH SICKLE CELL DISEASE (SCD) LONGITUDINALLY USING ELECTRONIC PATIENT-REPORTED OUTCOMES (PRO), ACTIGRAPHY AND BIOMARKERS (ELIPSIS)
Sara Zarnegar	662
REPPAIR TRIAL: REDUCING PROCEDURAL PAIN AND IMPROVING RECOVERY OF QUALITY OF LIFE IN PEDIATRIC NEUROBLASTOMA PATIENTS UNDERGOING BONE MARROW PROCEDURES, A PROSPECTIVE, RANDOMIZED, CROSS-OVER CLINICAL TRIAL
Jessica Zimmerman	039
TWO CASES OF EBF1-PDGFRB FUSION B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH SIMILAR CLINICAL PRESENTATIONS AND TREATMENT BUT DIFFERENT OUTCOMES AT THE UNIVERSITY OF IOWA

The 2018 ASPHO Conference

Accepted Papers and Posters

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z